FDA Accepts Regeneron and Sanofi’s DUPIXENT (Dupilumab) sBLA for Priority Review
Final Judgment and Order of Permanent Injunction Entered in Immunex v. Samsung Bioepis Etanercept Biosimilar Litigation
Sandoz to begin Phase III trial of aflibercept biosimilar
Subscribe: Subscribe via RSS
Blogs
Firm/Org